| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/15/2004 | WO2004059011A1 Heterocyclic fret dye cassettes for labeling biological molecules and their use in dna sequencing |
| 07/15/2004 | WO2004059009A1 A method of real-time detection of nucleic acid sequences |
| 07/15/2004 | WO2004059008A2 Polymorhisms in the dihydropyrimidase gene |
| 07/15/2004 | WO2004059007A2 Nucleic acid methylation detection process using an internal reference sample |
| 07/15/2004 | WO2004059006A1 Optical dna sensor, dna reading apparatus, identification method of dna and manufacturing method of optical dna sensor |
| 07/15/2004 | WO2004059005A2 Combined exponential and linear amplification |
| 07/15/2004 | WO2004059004A2 Method for the quantitative assessment of global and specific dna repair capacities of at least one biological medium, and the applications thereof |
| 07/15/2004 | WO2004059003A2 Incorporation of hapten groups during the production of carriers for the determination of analytes |
| 07/15/2004 | WO2004059002A2 Method for determining the homeostasis of hairy skin |
| 07/15/2004 | WO2004059001A2 Method for determining markers of human facial skin |
| 07/15/2004 | WO2004059000A2 High-throughput screening method for identifying active substances by means of co-cultivation |
| 07/15/2004 | WO2004058999A2 Method and means for determining specific conditions or changes in the uterine epithelium and in the epithelium of other organs |
| 07/15/2004 | WO2004058998A1 Method for the preparation of a collection of biological sample material, and sample collection |
| 07/15/2004 | WO2004058997A1 A kit for identifying lactobacillus by polymerase chain reaction |
| 07/15/2004 | WO2004058995A1 Culture medium and method for glycopeptide resistance testing in gram positive bacteria |
| 07/15/2004 | WO2004058994A1 Process for preparation of enzyme electrode |
| 07/15/2004 | WO2004058993A1 Lactate biosensing strip |
| 07/15/2004 | WO2004058992A1 Method for preparing lactate biosensing strip |
| 07/15/2004 | WO2004058991A1 Method for determining the enzymatic status of human skin in vitro |
| 07/15/2004 | WO2004058990A2 Genetic polymorphisms associated with stenosis, methods of detection and uses thereof |
| 07/15/2004 | WO2004058989A2 Target-dependent transcription |
| 07/15/2004 | WO2004058988A2 Binding agents which inhibit myostatin |
| 07/15/2004 | WO2004058987A2 Nucleic acid amplification |
| 07/15/2004 | WO2004058986A2 Btl-ii nucleic acids, proteins, and antibodies |
| 07/15/2004 | WO2004058985A2 Rapid direct sequence analysis of multi-exon genes |
| 07/15/2004 | WO2004058969A1 Preventives/remedies for cancer |
| 07/15/2004 | WO2004058958A1 Coenzyme-binding glucose dehydrogenase |
| 07/15/2004 | WO2004058956A1 Malate dehydrogenase as a target for herbicides |
| 07/15/2004 | WO2004058948A2 In vivo methods for validating the role of a tumor maintenance gene |
| 07/15/2004 | WO2004058945A2 Comparative genomic hybridization assays using immobilized oligonucleotide features and compositions for practicing the same |
| 07/15/2004 | WO2004058815A2 Centrosome-associated protein and applications thereof |
| 07/15/2004 | WO2004058793A1 Nucleotide derivatives and dna microarray |
| 07/15/2004 | WO2004058392A2 Intramolecular triplet-sensitized o-nitrophenylethyl photoprotective groups |
| 07/15/2004 | WO2004058391A2 Photoactivatable two-stage protective groups for the synthesis of biopolymers |
| 07/15/2004 | WO2004058300A1 Sequences diagnostic for foot and mouth disease |
| 07/15/2004 | WO2004058288A1 Novel therapeutic targets in cancer |
| 07/15/2004 | WO2004058175A2 Novel use of liver x receptor agonists |
| 07/15/2004 | WO2004058167A2 Breast specific protein expressed in cancer and methods of use thereof |
| 07/15/2004 | WO2004058166A2 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 07/15/2004 | WO2004058154A2 Method of identifying therapeutic agents |
| 07/15/2004 | WO2004058146A2 Novel compositions and methods in cancer |
| 07/15/2004 | WO2004058052A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 07/15/2004 | WO2004058050A2 Amplified cancer target genes useful in diagnosis and therapeutic screening |
| 07/15/2004 | WO2004058042A2 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 07/15/2004 | WO2004048606A3 Porcine polymorphisms and methods for detecting them |
| 07/15/2004 | WO2004047978A3 1microarrays and production thereof |
| 07/15/2004 | WO2004046370A3 Digital karyotyping |
| 07/15/2004 | WO2004046320A3 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
| 07/15/2004 | WO2004044221A3 High throughput automatic nucleic acid isolation and quantitation methods |
| 07/15/2004 | WO2004043991A3 Assay for tissue factor and factor viia |
| 07/15/2004 | WO2004043227A3 Polynucleotides for the amplification and detection of chlamydia trachomatis and neisseria gonorrhoeae |
| 07/15/2004 | WO2004042391A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a) |
| 07/15/2004 | WO2004042387A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1) |
| 07/15/2004 | WO2004042386A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3) |
| 07/15/2004 | WO2004042016A3 Real-time pcr primers and probes for identification as ralstonia solanacearum race 3, biovar 2 in potato |
| 07/15/2004 | WO2004041076A3 Methods of detecting colorectal cancer |
| 07/15/2004 | WO2004037848A9 Process for determining target function and identifying drug leads |
| 07/15/2004 | WO2004035813A3 Screening molecules with anti-prion activity: kits, methods and screened molecules |
| 07/15/2004 | WO2004031729A3 Diagnostic for long term response of hbv carrier to 3tc therapy |
| 07/15/2004 | WO2004031412A3 Method for diagnosing pancreatic cancer |
| 07/15/2004 | WO2004027081A3 Methods and composition for detecting targets |
| 07/15/2004 | WO2004026260A3 Prophylactic and therapeutic hiv aptamers |
| 07/15/2004 | WO2004024879A3 RORs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 07/15/2004 | WO2004024744A3 Production of glycosylated macrolides in e. coli |
| 07/15/2004 | WO2004023146A3 Methods for assaying protein-protein interactions |
| 07/15/2004 | WO2004023097A3 Homocysteine assay adaptable to screening |
| 07/15/2004 | WO2004017041A3 High resolution flow cytometer |
| 07/15/2004 | WO2004014296A3 Method of detecting and preventing alzheimer’s disease, particularly at prodromal and early stages |
| 07/15/2004 | WO2004013284A3 A method to assess genomic dna methylation using high-performance liquid chromatography-electospray ionization mass spectrometry |
| 07/15/2004 | WO2004012847A9 Sim2 polypeptides and polynucleotides and uses of each in diagnosis and treatment of ovarian, breast and lung cancers |
| 07/15/2004 | WO2004011905A3 Quality assurance/quality control for electrospray ionization processes |
| 07/15/2004 | WO2004010927A3 Method for increasing insulin sensitivity and for treating and preventing type 2 diabetes |
| 07/15/2004 | WO2004007664A3 Nucleic acid vectors |
| 07/15/2004 | WO2004005478A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/15/2004 | WO2004005322A3 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 07/15/2004 | WO2003104251A3 Composition and methods for obtaining nucleic acids from sputum |
| 07/15/2004 | WO2003102239B1 Met/fret based method of target nucleic acid detection whereby the donor/acceptor moieties are on complementary strands |
| 07/15/2004 | WO2003100033A3 ANTI-αvβ6 ANTIBODIES |
| 07/15/2004 | WO2003099209A3 Compositions and methods for screening and identifying anti-hcv agents |
| 07/15/2004 | WO2003098190A3 Protein identification from protein product ion spectra |
| 07/15/2004 | WO2003097808A3 Automated system for isolating, amplyifying and detecting a target nucleic acid sequence |
| 07/15/2004 | WO2003093422A3 Novel tissue factor targeted antibodies as anticoagulants |
| 07/15/2004 | WO2003092715A3 Proteins involved in the regulation of energy homeostasis |
| 07/15/2004 | WO2003089894A3 Isothermal amplification in nucleic acid analysis |
| 07/15/2004 | WO2003087391A3 Hydrophobic zone device |
| 07/15/2004 | WO2003087108A3 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003087040A3 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003083056A3 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof |
| 07/15/2004 | WO2003070965A9 The eaat2 promoter and uses thereof |
| 07/15/2004 | WO2003070883A3 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules. |
| 07/15/2004 | WO2003068938A3 Human fetal bladder-derived epithelial cells |
| 07/15/2004 | WO2003063893B1 Fgfr agonists |
| 07/15/2004 | WO2003047506A3 Peptide agonists of prostate-specific antigen, and uses therefor |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | WO2002097112A3 Catalytic amplification of multiplexed assay signals |
| 07/15/2004 | WO2002081636A3 Protein modification and maintenance molecules |
| 07/15/2004 | WO2002018619A3 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 07/15/2004 | US20040138824 Linkage analysis using direct and indirect counting |
| 07/15/2004 | US20040138543 Assembly of single use sensing elements |
| 07/15/2004 | US20040138443 Comprises nucleotide sequences coding interleukin receptor ligand for enhancing stimulation and regulation of host response to injury and infection |